See the DrugPatentWatch profile for Insulin
The price of insulin degludec/insulin aspart (Ryzodeg) can vary based on several factors, including dosage, formulation, insurance coverage, and geographic location.
How much does Ryzodeg cost without insurance?
Without insurance, a prescription for Ryzodeg can range significantly. For example, a 5-pen pack of Ryzodeg 70/30 100 units/mL can cost approximately $800 to $900 [1]. The exact retail price will depend on the pharmacy.
Can I get a Ryzodeg discount or coupon?
Several programs and coupons are available to help reduce the out-of-pocket cost of Ryzodeg. Manufacturer savings cards and discount programs offered by pharmacies can lower the price for eligible individuals. These programs often have specific terms and conditions regarding coverage and eligibility [2].
What is the price of Ryzodeg with insurance?
Insurance coverage for Ryzodeg significantly impacts its cost. With commercial insurance, copays can range from $0 to $150 or more per prescription, depending on the specific plan and formulary. Medicare Part D plans may have different copay structures, often falling into specific tiers with associated costs [2].
When does the patent for insulin degludec expire?
The patent landscape for insulin degludeg is complex, involving multiple patents that expire at different times. According to DrugPatentWatch.com, the earliest U.S. patent for insulin degludec is set to expire in late 2027, with other related patents extending further into the future, potentially into the mid-2030s [3]. These patent expirations are critical for the potential introduction of generic or biosimilar versions, which could influence pricing.
What is insulin degludec/insulin aspart used for?
Insulin degludec/insulin aspart is a combination rapid-acting and long-acting insulin. It is used to improve glycemic control in adults and children aged one year and older with diabetes mellitus [4]. This combination is designed to cover both mealtime insulin needs and basal (long-acting) insulin requirements.